ArticleFrontiers in oncology2020

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A.

Hailing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.